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A B S T R A C T
Objectives: To assess the relationship between cold-knife conization specimen height, cervical
intraepithelial neoplasia (CIN II/III) size and endocervical margin involvement by CIN II/II.
Study design: A cross-sectional study was performed. Cold knife cone specimens with a diagnosis of CIN
II/III were selected. Epidemiological data and pathology reports were obtained through a chart review. All
samples from each cone specimen showing CIN II/III and the squamocolumnar junction were selected.
Cone height (mean  standard deviation), intraepithelial lesion size, and size of endocervical surgical
margins were measured.
Results: Four hundred and forty-seven samples were analyzed from 97 cone specimens. Section size
ranged from 3.4 to 29.7 mm, tumor size from 0.3 to 17.5 mm, and tumor distance from the endocervical
margin, from 0.0 to 22.0 mm. Age and parity were similar in the positive vs. negative margin groups
(37.6  10.0 years vs. 37.7  11.9 years respectively, p = 0.952, and 2.2  1.7 births vs. 2.6  1.9 births
respectively, p = 0.804), whereas cone height (22.4  6.9 mm vs. 17.1  5.6 mm, p = 0.013) and tumor size
(6.12  3.25 mm vs. 10.6  4.45 mm, p < 0.001) were signiﬁcantly different in negative vs. positive margin
groups respectively.
Conclusions: Use of cone height to identify the likelihood of negative margins enables better estimation of
the risk–beneﬁt ratio of greater risks of bleeding, stenosis, and obstetric complications (cervical
incompetence) versus greater risks of residual and recurrent disease.
 2012 Elsevier Ireland Ltd. 
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Early stage cervical cancer is a curable condition with
adequately diagnosed and staged treatment and in the presence
of an appropriate management plan [1]. In the United States in
2010, cervical cancer was the third most common gynecological
malignancy: 12,200 new cases were diagnosed and approximately
4210 women died of cervical cancer [2]. The disease is most
commonly diagnosed in the ﬁfth decade of life, several years before
the mean age at diagnosis of breast, lung, and ovarian cancer [3]. In
Brazil, it is the second most common malignancy in the female
population, outranked only by breast cancer, and the fourth
leading cause of cancer-related mortality in women, with 18,430* Corresponding author at: Servic¸o de Ginecologia e Obstetrı´cia, Hospital de
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Open access under the Elsevier OA license.new cases and 4800 deaths each year [4]. In England, the NHS
Cervical Screening Programme is able to screen approximately 80%
of the women population who should be submitted to screening
for cervical cancer and pre-invasive lesions. This screening is done
with liquid cytology and molecular biology tests for HPV [5]. In
Brazil, unfortunately, pap smear coverage is under 20% of eligible
women and the liquid cytology and molecular biology tests for
HPV are not available in the national health system [6].
Recently, a systematic review assessed 103 studies with data
from more than 12 million patients [7]. The incidence of high-
grade squamous intraepithelial lesions (HSIL) in European women
was found to be highest between 30 and 40 years old. This is
similar to the age incidence in South America, but higher than in
North America. The peak age of incidence of low-grade lesions
(LSIL) was much lower than HSIL, with a decline through the years.
It is interesting to observe that while several population-based
studies in European countries showed around 80% of screening
coverage and prevention of uterine cervical cancer, studies that
analyzed countries from Central and South America showed only
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cancer.
Treatment of cervical intraepithelial neoplasia II/III (CIN II/III) is
determined by colposcopy ﬁndings. When colposcopy is satisfactory
(visible squamocolumnar junction), both ablative and excisional
methods are adequate [8]. There is broad consensus that the entire
transformation zone must be removed if treatment is to be effective
[9]. Involvement of surgical margins on pathological examination is
an established risk factor for recurrence and persistence of cervical
intraepithelial neoplasia (CIN) [10–12].
The surgical treatment of several tumors, including melanoma
[13], breast cancer [14], and vulvar intraepithelial neoplasia or
vulvar carcinoma [15], involves complete excision of the tumor
with predeﬁned margins. In the ﬁeld of cervical pathology, there is
no clear deﬁnition of the minimum amount of cervical canal that
should be removed during cone biopsy, thus creating the
possibility of incomplete resection of high-grade lesions. Negative
surgical margins on conization are associated with lower odds of
high-grade lesion recurrence [15–17].
The objective of this study was to assess the relationship
between height of cold-knife conization specimens, size of CIN II/III
lesions and CIN II/III endocervical margin involvement.
2. Materials and methods
2.1. Population and sample
This was a prospective cross-sectional study, conducted on a
sample of patients diagnosed with HSIL on cold-knife cone biopsy
and treated at the Female Genital Oncology Service of the Hospital
de Clinicas de Porto Alegre (HCPA), University Hospital, Depart-
ment of Obstetrics and Gynecology between June 2000 and
September 2007. All patients who underwent cold-knife coniza-
tion and received a diagnosis of CIN II/III were included. Data were
collected by means of a chart review.
Sample size was calculated using the PEPI 4.0 software
application. Considering a prevalence rate of endocervical margin
involvement of 10% [16–18], a conﬁdence level of 95%, and a
margin of error of 6%, the minimum sample size was estimated at
97 patients.
Patients who underwent a loop electrosurgical excisional
procedure (LEEP), ablative therapy or total hysterectomy were
excluded, as were patients whose cone biopsy specimens showed
no CIN II/III or showed microinvasive or invasive squamous or
glandular lesions.
2.2. Procedures
A retrospective review of patient charts was carried out with
the purpose of collecting demographic, preoperative (diagnostic),
postoperative (anatomical and pathologic), and clinical follow-up
data. Data were collected on age, birth date, skin color (reported as
white, black, or brown), age at the time of conization, parity,
menopause status, cervical cytology (normal; ASC-US, atypical
cells of undetermined signiﬁcance; ASC-H, atypical squamous
cells, cannot exclude HSIL; AGC, atypical glandular cells; LSIL, low-
grade squamous intraepithelial lesion; HSIL, high-grade squamous
intraepithelial lesion; invasive squamous cell carcinoma of the
cervix; adenocarcinoma in situ; invasive adenocarcinoma) and
prior biopsy ﬁndings, colposcopy ﬁndings, size and location of the
lesion within the cervix, greater bleeding than expected during the
procedure, and late complications (cervical stenosis, hematometra,
chronic pelvic pain) related to the procedure.
All slides from each patient were selected. Those containing a
sample of the CIN II/III, of the squamocolumnar junction and sliced
so as to include the entire stretch of tissue from the ectocervix tothe endocervical margin were selected. All slides were stained with
hematoxylin and eosin (H&E), and measurements were obtained
with a Diagtech brand stereoscopic microscope, using a 10
eyepiece and 0.7–4.0 lenses. A Holtermann brand 1 cm:100
melanoma reticle MH-1 model was attached to the eyepiece to
facilitate measurement.
2.3. Pathology assessment
Conization was performed by incising through the anterior lip
of the cervix at the 12 o’clock position, on a plane parallel to the
axis of the cervical canal. Specimens were ﬁxed and 3–4 mm slices
were obtained, also parallel to the axis of the cervical canal. The
following data were obtained from pathology reports for the
purpose of this study: measurements of the cone biopsy specimen
(height and width) and surgical margins.
Specimens from all patients were reassessed and new
measurements obtained of cone height, size of the CIN II/III from
the ectocervix to the endocervix, and endocervical margins.
Margins were considered positive when the distance between
the intraepithelial lesion and the point of transection of the
endocervical canal was 0.5 mm [19].
Cone biopsy specimens were described according to (a) cone
height (depth of the cervical canal segment removed) in
millimeters, (b) CIN II/III size in millimeters, and (c) endocervical
margin status.
2.4. Follow-up
Patient follow-up was carried out according to established
protocols of the Female Genital Oncology Service of the Hospital de
Clinicas de Porto Alegre (HCPA), Department of Obstetrics and
Gynecology. One to two weeks after surgery, patients had their
postoperative follow-up appointment, which consisted of a
gynecological examination and a review of pathology ﬁndings.
Patients were then followed every 4 months for 2 years and every 6
months thereafter.
2.5. Ethical aspects
The present study was conducted in compliance with the
Brazilian Guidelines and Regulations on Human Subject Research
(National Health Council Resolution 196/96) and was approved by
the Hospital de Clı´nicas de Porto Alegre Graduate Research Group
Ethics Committee (GPPG 08-085). All authors signed data
collection forms.
2.6. Statistical analysis
The qualitative variables age, parity, cone height, cone width,
CIN II/III size, and endocervical margins were tested for normality
with the Shapiro–Wilk test, described as means and standard
deviations, and compared using Student’s t test.
The remaining variables – skin color, menopause status, pre-
conization colposcopy ﬁndings (squamocolumnar junction visual-
ization, atypical transformation zone (ATZ), and lesion extension
into the endocervical canal), pre- and post-conization cytopathol-
ogy ﬁndings, cone biopsy pathology ﬁndings, intraoperative
bleeding (within or beyond expectations), surgical margin
involvement, stenosis, lesion recurrence, and need for reinterven-
tion – were described as absolute and relative frequencies.
Pearson’s chi-square test and Fisher’s exact test were used as
appropriate for between-group comparisons.
Data were analyzed in the SPSS (Statistical Package for the
Social Sciences) 17.0 environment. Statistical signiﬁcance was
deﬁned as p < 0.05.
Table 2
Section size, tumor size and distance between tumor and endocervical surgical
margin.
Min (mm) Max (mm) Mean  SD (mm)
Section size 3.4 29.7 15.4  4.1
Tumor size 0.3 17.5 4.9  3.2
Distance between tumor and
endocervical surgical margin
0.0 22.0 7.3  4.6
Table 3
Tumor size and cumulative percentage (n = 447).
Tumor size  (mm) Overall percentage (%)
5.0 58.4
6.0 68.9
7.0 76.7
8.0 84.8
9.0 88.1
10.0 92.6
11.0 93.9
12.0 96.9
13.1 97.5
14.2 98.6
16.4 99.5
17.5 100.0
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A total of 447 slices from 97 patients were analyzed. Patient age
ranged from 18 to 66 years. The mean age, parity, race, menopausal
status, satisfactoriness of colposcopy, presence and degree of ATZ,
results of previous cytology and biopsy and complications,
associated with the state of potential involvement of margins,
are presented in Table 1. The mean follow-up was 160 days.
Prior cytopathology was negative in only 5.5% of patients,
involving squamocolumnar junction in 60% of these.
Cone width and height, intraepithelial lesion size, and distance
between intraepithelial lesion and endocervical margin (ranges
and mean  standard deviation) are shown in Table 2.
Of the 447 specimens analyzed, 76.3% showed lesions <7.0 mm
in size, 88.1% showed lesions < 9.0 mm and 93.9% showed lesions
<11.0 mm. No samples contained lesions larger than 17.5 mm
(Table 3).
Cone height was signiﬁcantly associated with margin involve-
ment (p = 0.013): patients with positive margins had smaller cone
heights than those with negative margins (Table 4). Tumor size
was also signiﬁcantly associated with margin involvement
(p < 0.001), with patients with more extensive intraepithelial
lesions being more likely to have positive margins (Table 1).Table 1
Epidemiological data, pre-tests of the cone, procedure, analysis of the cone and the
monitoring of patients regarding the potential involvement of endocervical
margins.
Free margin Margin envolvement p
Skin (n = 97) 1.000a
White 70 19
Black 5 1
Mixed 1 0
Missing data 1
Age 37.6  10.04 37.7  11.95 0.952b
Menopausal status (n = 90) 0.408a
Menacme 71 (87.7%) 10 (12.3%)
Post-menopausal 7 (77.8%) 2 (22.2%)
Parity (n = 85) 2.2  1.7 2.6  1.9 0.804b
Previus CP (n = 91) 0.489a
HSIL 38 (52.8%) 10 (52.6%)
Other diagnosis 31 (43.0%) 7 (36.9%)
Negative for malignancy 3 (4.2%) 2 (10.5%)
Biopsy (n = 88) 0.611a
CIN II/III 61 (88.4%) 18 (94.7%)
CIN I 5 (7.2%) 0
Carcinoma 2 (2.9%) 1 (5.3%)
Non neoplastic 1 (1.5%) 0
Colposcopy (n = 85) 0.275a
Satisfactory 68 (91.9%) 9 (81.8%)
Unsatisfactory 6 (8.1%) 2 (18.2%)
Presence of ATZ (n = 77) 0.172a
Minor changes 14 (22.5%) 1 (6.3%)
Major changes 47 (77.5%) 15 (93.7%)
Superﬁcial lesion size (mm) 6.2  3.25 10.6  4.45 <0.001b
Cone height (mm) 22.4  6.9 17.1  5.6 0.013b
Complications (n = 88) 0.580a
Bleeding 5 1
Stenosis 12 4
Recurrence of the lesion 15.5% 46.3%
CP, cytopathological; HSIL, high-grade intraepithelial lesion; CIN, cervical
intraepithelial neoplasia; ATZ, atypical transformation zone.
a Fisher’s exact test.
b Student t-test.4. Comments
This study analyzed the relationships between cold-knife
conization specimens, intraepithelial lesion size, and CIN II/III with
endocervical margin involvement. It is important to remember that
individuals and organs have varying sizes and morphology.
Proper pre-conization assessment is key, and can be a
determining factor of cure. Rates of satisfactory colposcopy
(visualization of the squamocolumnar junction) were higher than
those reported in the literature, where 77.5% of patients
undergoing conization for CIN II/III had satisfactory colposcopy
[20]. Del Pino et al. reported that 72% of patients with CIN II/III had
satisfactory colposcopies [21], but only 41% and 46% had high-
grade or low-grade atypical transformation zones, and 13% had no
colposcopically identiﬁable lesions. These rates show a weaker
correlation between transformation zone grade and intraepithelial
lesion than those found in the present study.
Excisional procedures (LEEP, laser conization, and cold-knife
conization) enable detailed assessment of all resected tissues. This
reduces the risk of inadvertent treatment of occult microinvasive
or invasive carcinoma as a pre-invasive lesion. Unsatisfactory
colposcopy (that is, when there is no visualization of the
squamocolumnar junction) is associated with up to a 7% risk of
occult invasive carcinoma in the conization specimen in patients
diagnosed as having CIN II/III on prior biopsy. Therefore, diagnostic
and therapeutic conization procedures, which allow pathologic
examination of endocervical canal tissue, are usually recom-
mended in women with biopsy ﬁndings of CIN II/III andTable 4
Tumor size, cumulative percentage and cone height to obtain free endocervical
margins.
Tumor size < (mm) Overall
percentage (%)
Tumor + 0.5 mm margin + 10%
(cone height – mm)
6.0 68.9
8.0 84.8 9.35
10.0 92.6
12.0 96.9 13.75
14.2 98.6
17.5 100.0 19.80
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whether any differences exist between cold-knife conization and
LEEP regarding endocervical margin involvement. Some authors
report that endocervical margins are less frequently positive and
easier to interpret with cold-knife conization as compared to LEEP
[19,23,24].
Rates of HSIL, LSIL, ASC-US, ASC-H, and AGUS were similar to
those reported in the literature [25]
In this study, 40.2% of cone specimens had positive margins. The
presence of margin involvement after cervical conization has been
reported with extremely variable rates in the literature: 7.2–42.5%
[16,17,26]. The rate depends mostly on margin type. If endocervi-
cal margins are considered regardless of ectocervical margin
involvement, the positivity rate is approximately 10% [16–18].
Some authors have reported disease recurrence and residual
disease rates of 5–10% and 20–35% in hysterectomy specimens. In
this study, in the free margins group the recurrence rate was 15.5%,
and in the margin involvement group, 46.3%. Studies of total or
subtotal excision of intraepithelial lesions have shown that
residual disease must be treated and that disease recurs even
when complete resection of the original lesion (that is, with
negative or clear margins) is achieved. Furthermore, these studies
have shown the importance of follow-up after excisional
treatment, to enable early detection of residual or recurrent
disease [16,18,27].
When performed at the time of the diagnostic excisional
procedure, endocervical curettage correlates with endocervical
margin status. Margin involvement on endocervical curettage is a
predictor of residual disease in subsequent procedures. The
prevalence of margin involvement on conization and the odds of
residual lesions are directly associated with cervical lesion severity
[28].
In the present study, age, parity, and menopausal status were
not signiﬁcantly associated with endocervical margin involve-
ment. These ﬁndings are consistent with those reported by Chen
et al. [23]. Age >50 years and incomplete excision have been
established as independent risk factors for recurrence after LEEP
conization for CIN II/III [18]. In adenocarcinoma in situ, negative
conization margins are no guarantee of absence of residual lesions
on hysterectomy. Some studies have reported 30–45% rates of
residual lesions with negative margins [28].
Recurrence or persistence of CIN is more frequent in women
with surgical margin involvement. Multivariate analyses adjusted
for other cofactors have shown that margin status is not an
independent predictor of residual disease [27]. Some authors have
recently shown that margin involvement on LEEP and positive
endocervical biopsy are histological predictors of residual cervical
disease [29]. Furthermore, it should be borne in mind that the
majority of patients with margin involvement remain disease-free
throughout follow-up [16]. Up to 40% of patients undergoing LEEP
are found to have had incomplete excision of CIN lesions on
histopathological examination of specimen margins. Accordingly,
most studies recommend that women with positive margins be
informed of the relative risks of watchful waiting versus additional
treatment. Management should be individualized on the basis of
desired fertility, age, patient preference, and other factors. When
patients choose to have additional treatment, the risk of
complications must be weighed against the desire to eradicate
potential residual CIN. Hysterectomy remains appropriate in
judiciously selected cases [8,16].
The 19% rate of margin involvement is consistent with the
literature. CIN II/III-positive margin rates of 19% and 16% have been
reported for cold-knife conization and LEEP respectively [19]. In
another study, the rates of margin involvement with these same
methods were 5.7% and 33% respectively [30]. As cold-knife
conization is generally associated with greater cone heights, it isnaturally associated with a lower incidence of margin involvement
[31]. Ueda et al. reported a 12.3% rate of margin involvement after
laser excision of the cervix, although margins were not speciﬁed as
ectocervical or endocervical [32].
In the absence of deﬁnitive data on the optimal minimum
distance between lesions and surgical margins, it has long been
recommended that margins be as wide as possible [28]. Greater
cone heights, however, are conclusively associated with greater
risk of stenosis [33], bleeding [34], and preterm labor, low birth
weight, and perinatal mortality in subsequent pregnancies [35].
Milinovic et al. found no endocervical margins compromised in any
cone more than 18 mm deep, suggesting that this is the maximum
height to be resected to minimize future obstetric complications
[36].
From the cumulative percentages shown in Table 3, one may
infer that, as surgical specimens lose 10% of volume during
histological processing and a minimum endocervical margin of
0.5 mm is recommended [19], the likelihood of complete resection
of CIN II/III is approximately 100% with a cone height of 20.0 mm,
95% with a cone height of 13.0 mm and 90% with a cone height of
11.0 mm. These data may be used to calculate the risk of margin
involvement, taking into account age, expectation of pregnancy,
and immune status, and thus helping to weigh the risk of greater
cone height and increased odds of stenosis versus smaller cone
height and increased odds of residual or recurrent disease.
The results presented herein may assist in personalizing the
choice of procedure according to patient characteristics. Thus,
considering the patient’s age, her immune status and her desire to
become pregnant, the cone should be smaller, ranging from 10 to
14 mm considering the percentage chance of free margins in the
order of 84–97%. In cases where fertility is not a concern or where
the patient does not have a good immune status, the cone may be
deeper, reaching heights up to 20 mm in order to achieve a 100%
chance of free margins. By using cone height to identify the risk of
positive margins, one may estimate the risk–beneﬁt ratio of greater
risks of intraoperative bleeding, stenosis, and obstetric complica-
tions (cervical incompetence) versus greater risks of residual
disease and disease recurrence.
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